Evidence map›Paper›PMID 25684426›Full record

ArticleBioorganic & medicinal chemistry2015

3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.

Astha Verma, Dawn M Wong, Rafique Islam, Fan Tong, Maryam Ghavami, James M Mutunga, Carla Slebodnick, Jianyong Li, Elisabet Viayna, Polo C-H Lam and 3 more

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Structural dynamics (Melville, N.Y.) · 2021
    Article
  3. Article
  4. The synthetic and therapeutic expedition of isoxazole and its analogs.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2018
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Astha VermaDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Dawn M WongDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Rafique IslamDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Fan TongDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Maryam GhavamiDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
James M MutungaDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Carla SlebodnickDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Jianyong LiDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Elisabet ViaynaDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Polo C-H LamMolsoft LLC, 11199 Sorrento Valley Road, San Diego, CA 92121, USA.
Maxim M TotrovMolsoft LLC, 11199 Sorrento Valley Road, San Diego, CA 92121, USA.
Jeffrey R BloomquistDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Paul R CarlierDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA. Electronic address: pcarlier@vt.edu.
Virginia Tech · USUniversity of Florida · USMolsoft (United States) · US

Funding

Development of vector-specific, resistance-breaking insecticides to reduce malariR01AI082581 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI CARLIER, PAUL R · 2009 to 2013
$3.4M
NIAID NIH HHS AI082581NIAID NIH HHS R01 AI082581
6 · The paper itself

Abstract

To identify potential selective and resistance-breaking mosquitocides against the African malaria vector Anopheles gambiae, we investigated the acetylcholinesterase (AChE) inhibitory and mosquitocidal properties of isoxazol-3-yl dimethylcarbamates (15), and the corresponding 3-oxoisoxazole-2(3H)-dimethylcarboxamide isomers (14). In both series, compounds were found with excellent contact toxicity to wild-type susceptible (G3) strain and multiply resistant (Akron) strain mosquitoes that carry the G119S resistance mutation of AChE. Compounds possessing good to excellent toxicity to Akron strain mosquitoes inhibit the G119S mutant of An. gambiae AChE (AgAChE) with ki values at least 10- to 600-fold higher than that of propoxur, a compound that does not kill Akron mosquitoes at the highest concentration tested. On average, inactivation of WT AgAChE by dimethylcarboxamides 14 was 10-20 fold faster than that of the corresponding isoxazol-3-yl dimethylcarbamates 15. X-ray crystallography of dimethylcarboxamide 14d provided insight into that reactivity, a finding that may explain the inhibitory power of structurally-related inhibitors of hormone-sensitive lipase. Finally, human/An. gambiae AChE inhibition selectivities of these compounds were low, suggesting the need for additional structural modification.

Indexed as

MalariaAcetylcholinesteraseAnimalsAnophelesCarbamatesCholinesterase InhibitorsDose-Response Relationship, DrugHumansIsoxazolesMolecular StructureStructure-Activity RelationshipAcetylcholinesteraseCarbamatesCholinesterase InhibitorsIsoxazolesAcetylcholinesteraseAnopheles gambiaeCarbamateCarboxamideMalaria

Identifiers

PMID25684426
PMCPMC4346421
OpenAlexW1978208718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.